StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.36+0.26 (+12.38%)

Close on Nov 17, 2026Market cap $300.60MP/E –Yield –

Nautilus Biotechnology operating margin

Operating margin is operating income as a percentage of revenue.

No operating margin figures for Nautilus Biotechnology

Nautilus Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nautilus Biotechnology figures

See a number that looks wrong?